Cisplatin Induced Kidney Toxicity

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

April 1, 2026

Study Completion Date

December 31, 2028

Conditions
Acute Kidney InjuryCancer
Interventions
OTHER

Questionnaire, sampling of blood, urine and saliva

We are following patients who are receiving Cisplatin as part of their cancer therapy.

Trial Locations (1)

N6A 5W9

RECRUITING

London Health Sciences Centre, London

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

London Health Sciences Centre

OTHER

collaborator

Provincial Health Services Authority

OTHER

lead

The Hospital for Sick Children

OTHER